126 related articles for article (PubMed ID: 20429003)
1. Lung tumor radiofrequency ablation: where do we stand?
de Baère T
Cardiovasc Intervent Radiol; 2011 Apr; 34(2):241-51. PubMed ID: 20429003
[TBL] [Abstract][Full Text] [Related]
2. Single-session radiofrequency ablation of bilateral lung metastases.
Palussière J; Gómez F; Cannella M; Ferron S; Descat E; Fonck M; Brouste V; Avril A
Cardiovasc Intervent Radiol; 2012 Aug; 35(4):852-9. PubMed ID: 21647807
[TBL] [Abstract][Full Text] [Related]
3. Determinants of local progression after computed tomography-guided percutaneous radiofrequency ablation for unresectable lung tumors: 9-year experience in a single institution.
Okuma T; Matsuoka T; Yamamoto A; Oyama Y; Hamamoto S; Toyoshima M; Nakamura K; Miki Y
Cardiovasc Intervent Radiol; 2010 Aug; 33(4):787-93. PubMed ID: 19967367
[TBL] [Abstract][Full Text] [Related]
4. Extending indications for radiofrequency ablation of lung tumors through an intraoperative approach.
Linden PA; Wee JO; Jaklitsch MT; Colson YL
Ann Thorac Surg; 2008 Feb; 85(2):420-3. PubMed ID: 18222236
[TBL] [Abstract][Full Text] [Related]
5. CT-guided radiofrequency heat ablation of malignant lung tumors.
Schaefer O; Lohrmann C; Ghanem N; Langer M
Med Sci Monit; 2003 Nov; 9(11):MT127-31. PubMed ID: 14586288
[TBL] [Abstract][Full Text] [Related]
6. Cancer-free survival and local tumor control after impendence-based radiofrequency ablation of biopsy-proven renal cell carcinomas with a minimum of 1-year follow-up.
Forauer AR; Dewey BJ; Seigne JD
Urol Oncol; 2014 Aug; 32(6):869-76. PubMed ID: 24946958
[TBL] [Abstract][Full Text] [Related]
7. Midterm local efficacy and survival after radiofrequency ablation of lung tumors with minimum follow-up of 1 year: prospective evaluation.
de Baère T; Palussière J; Aupérin A; Hakime A; Abdel-Rehim M; Kind M; Dromain C; Ravaud A; Tebboune N; Boige V; Malka D; Lafont C; Ducreux M
Radiology; 2006 Aug; 240(2):587-96. PubMed ID: 16864679
[TBL] [Abstract][Full Text] [Related]
8. Radiofrequency ablation of thoracic lesions: part 2, initial clinical experience--technical and multidisciplinary considerations in 30 patients.
VanSonnenberg E; Shankar S; Morrison PR; Nair RT; Silverman SG; Jaklitsch MT; Liu F; Cheung L; Tuncali K; Skarin AT; Sugarbaker DJ
AJR Am J Roentgenol; 2005 Feb; 184(2):381-90. PubMed ID: 15671350
[TBL] [Abstract][Full Text] [Related]
9. The efficacy of bipolar and multipolar radiofrequency ablation of lung neoplasms - results of an ablate and resect study.
Schneider T; Reuss D; Warth A; Schnabel PA; von Deimling A; Herth FJ; Dienemann H; Hoffmann H
Eur J Cardiothorac Surg; 2011 Jun; 39(6):968-73. PubMed ID: 20961771
[TBL] [Abstract][Full Text] [Related]
10. Radiofrequency ablation of liver metastases-software-assisted evaluation of the ablation zone in MDCT: tumor-free follow-up versus local recurrent disease.
Keil S; Bruners P; Schiffl K; Sedlmair M; Mühlenbruch G; Günther RW; Das M; Mahnken AH
Cardiovasc Intervent Radiol; 2010 Apr; 33(2):297-306. PubMed ID: 19688366
[TBL] [Abstract][Full Text] [Related]
11. Pulmonary radiofrequency ablation in patients with a single lung: feasibility, efficacy, and tolerance.
Hess A; Palussière J; Goyers JF; Guth A; Aupérin A; de Baère T
Radiology; 2011 Feb; 258(2):635-42. PubMed ID: 21273525
[TBL] [Abstract][Full Text] [Related]
12. Spontaneous regression of multiple pulmonary metastases after radiofrequency ablation of a single metastasis.
Rao P; Escudier B; de Baere T
Cardiovasc Intervent Radiol; 2011 Apr; 34(2):424-30. PubMed ID: 20532778
[TBL] [Abstract][Full Text] [Related]
13. Increase in fluorodeoxyglucose positron emission tomography activity following complete radiofrequency ablation of lung tumors.
Sharma A; Lanuti M; He W; Palmer EL; Shepard JA; Digumarthy SR
J Comput Assist Tomogr; 2013; 37(1):9-14. PubMed ID: 23321827
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of Tract Embolization After Percutaneous Pulmonary Radiofrequency Ablation.
Dassa M; Izaaryene J; Daidj N; Piana G
Cardiovasc Intervent Radiol; 2021 Jun; 44(6):903-910. PubMed ID: 33492452
[TBL] [Abstract][Full Text] [Related]
15. Percutaneous radiofrequency thermal ablation of primary and metastatic lung tumors.
Thanos L; Mylona S; Pomoni M; Athanassiadi K; Theakos N; Zoganas L; Batakis N
Eur J Cardiothorac Surg; 2006 Nov; 30(5):797-800. PubMed ID: 17000115
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for occurrence of local tumor progression after percutaneous radiofrequency ablation for lung neoplasms.
Yamagami T; Kato T; Hirota T; Yoshimatsu R; Matsumoto T; Shimada J; Nishimura T
Diagn Interv Radiol; 2007 Dec; 13(4):199-203. PubMed ID: 18092293
[TBL] [Abstract][Full Text] [Related]
17. Ultrasound-guided percutaneous radiofrequency ablation of small renal tumors: Clinical results and radiological evolution during follow-up.
Lyrdal D; Andersson M; Hellström M; Sternal J; Lundstam S
Acta Radiol; 2010 Sep; 51(7):808-18. PubMed ID: 20707665
[TBL] [Abstract][Full Text] [Related]
18. Outcome after radiofrequency ablation of sarcoma lung metastases.
Koelblinger C; Strauss S; Gillams A
Cardiovasc Intervent Radiol; 2014 Feb; 37(1):147-53. PubMed ID: 23670570
[TBL] [Abstract][Full Text] [Related]
19. [Percutaneous radiofrequency ablation of liver tumors using the LeVeen 4 cm array probe].
Pitton MB; Herber S; Raab P; Mönch C; Wunsch M; Schneider J; Schweden F; Otto G; Thelen M
Rofo; 2003 Nov; 175(11):1525-31. PubMed ID: 14610704
[TBL] [Abstract][Full Text] [Related]
20. Radiofrequency ablation in lung cancer: promising results in safety and efficacy.
Suh R; Reckamp K; Zeidler M; Cameron R
Oncology (Williston Park); 2005 Oct; 19(11 Suppl 4):12-21. PubMed ID: 16366374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
